1. Home
  2. MODD vs NOTV Comparison

MODD vs NOTV Comparison

Compare MODD & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Modular Medical Inc.

MODD

Modular Medical Inc.

N/A

Current Price

$0.36

Market Cap

33.0M

Sector

Health Care

ML Signal

N/A

Logo Inotiv Inc.

NOTV

Inotiv Inc.

N/A

Current Price

$0.63

Market Cap

29.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MODD
NOTV
Founded
1998
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.0M
29.9M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
MODD
NOTV
Price
$0.36
$0.63
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
529.2K
1.1M
Earning Date
11-14-2025
02-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$513,024,000.00
Revenue This Year
N/A
$6.26
Revenue Next Year
N/A
$45.49
P/E Ratio
N/A
N/A
Revenue Growth
N/A
4.54
52 Week Low
$0.28
$0.66
52 Week High
$1.59
$6.48

Technical Indicators

Market Signals
Indicator
MODD
NOTV
Relative Strength Index (RSI) 38.59 28.09
Support Level $0.32 $0.79
Resistance Level $0.42 $0.86
Average True Range (ATR) 0.04 0.07
MACD -0.00 -0.01
Stochastic Oscillator 33.37 4.76

Price Performance

Historical Comparison
MODD
NOTV

About MODD Modular Medical Inc.

Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

Share on Social Networks: